Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0068904
Title: Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma
Authors: Wang, W.-W.
Ang, S.F.
Kumar, R.
Heah, C.
Utama, A.
Tania, N.P.
Li, H.
Tan, S.H.
Poo, D.
Choo, S.P.
Chow, W.C.
Tan, C.K.
Toh, H.C. 
Issue Date: 18-Jul-2013
Citation: Wang, W.-W., Ang, S.F., Kumar, R., Heah, C., Utama, A., Tania, N.P., Li, H., Tan, S.H., Poo, D., Choo, S.P., Chow, W.C., Tan, C.K., Toh, H.C. (2013-07-18). Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma. PLoS ONE 8 (7) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0068904
Abstract: Early diagnosis of hepatocellullar carcinoma (HCC) remains a challenge. The current practice of serum alpha-fetoprotein (AFP) measurement is inadequate. Here we utilized a proteomic approach to identify novel serum biomarkers for distinguishing HCC patients from non-cancer controls. We profiled the serum proteins in a group of 58 resectable HCC patients and 11 non-HCC chronic hepatitis B (HBV) carrier samples from the Singapore General Hospital (SGH) using the RayBio® L-Series 507 Antibody Array and found 113 serum markers that were significantly modulated between HCC and control groups. Selected potential biomarkers from this list were quantified using a multiplex sandwich enzyme-linked immunosorbent assay (ELISA) array in an expanded SGH cohort (126 resectable HCC patients and 115 non-HCC chronic HBV carriers (NC group)), confirming that serum prolactin and monocyte chemoattractant protein-1 (MCP-1) were significantly upregulated in HCC patients. This finding of serum MCP-1 elevation in HCC patients was validated in a separate cohort of serum samples from the Mochtar Riady Institute for Nanotechnology, Indonesia (98 resectable HCC, 101 chronic hepatitis B patients and 100 asymptomatic HBV/HCV carriers) by sandwich ELISA. MCP-1 and prolactin levels were found to correlate with AFP, while MCP-1 also correlated with disease stage. Subsequent receiver operating characteristic (ROC) analysis of AFP, prolactin and MCP-1 in the SGH cohort and comparing their area under the ROC curve (AUC) indicated that neither prolactin nor MCP-1 on their own performed better than AFP. However, the combination of AFP+MCP-1 (AUC, 0.974) had significantly superior discriminative ability than AFP alone (AUC, 0.942; p
Source Title: PLoS ONE
URI: http://scholarbank.nus.edu.sg/handle/10635/110561
ISSN: 19326203
DOI: 10.1371/journal.pone.0068904
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0068904.pdf570.26 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

27
checked on Apr 15, 2021

WEB OF SCIENCETM
Citations

18
checked on Apr 15, 2021

Page view(s)

91
checked on Apr 11, 2021

Download(s)

1
checked on Apr 11, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.